OccamzRazor

New York, United States

OccamzRazor is a combines machine learning and first-in-class biological techniques to improve outcomes in drug discovery and development.

$6.1M raised

Mar 2022

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has OccamzRazor raised?

OccamzRazor has raised $6.1M in total funding. The most recent round was Series A. The last funding was announced in March 2022.

Who are OccamzRazor's investors?

OccamzRazor's investors include Valor Equity Partners, Human Capital, Michael J. Fox Foundation, Positive Ventures, Jeff Dean.

Where is OccamzRazor headquartered?

OccamzRazor is headquartered in New York, United States.

What does OccamzRazor do?

OccamzRazor is a combines machine learning and first-in-class biological techniques to improve outcomes in drug discovery and development.

What stage is OccamzRazor at?

OccamzRazor is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 8, 2022.

MLA

"OccamzRazor — Funding & Investors." VCBacked, March 8, 2022, https://www.vcbacked.co/company/occamzrazor. Accessed July 1, 2026.

APA

VCBacked. (2022). OccamzRazor — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/occamzrazor

Wikipedia (cite web)

{{cite web |title=OccamzRazor — Funding & Investors |url=https://www.vcbacked.co/company/occamzrazor |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 8, 2022.